DBVT
DBV Technologies S.A.
NASDAQ · Healthcare · Biotechnology · FR
$13.47
−1.68%Leverage
- Debt / equity
- 0.13x
- Net debt / equity
- -0.96x
- Debt / assets
- 0.09x
- Debt / EBITDA
- -0.12x
- Net debt / EBITDA
- 0.89x
Liquidity & coverage
- Current ratio
- 3.72x
- Quick ratio
- 3.72x
- Cash ratio
- 3.22x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $147.6M
Cash & dividend
- FCF / debt
- -9.56x
- Cash flow / debt
- -9.51x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026